Prelude Therapeutics Stock Forecast - Period Momentum Indicator
| PRLD Stock | USD 0.97 0.06 5.83% |
Prelude Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Prelude Therapeutics stock prices and determine the direction of Prelude Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Prelude Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Prelude |
| Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
| (0.08) | (0.08) |
| Check Prelude Therapeutics Volatility | Backtest Prelude Therapeutics | Trend Details |
Prelude Therapeutics Trading Date Momentum
| On December 02 2024 Prelude Therapeutics was traded for 1.05 at the closing time. The top price for the day was 1.08 and the lowest listed price was 1.03 . The trading volume for the day was 222.7 K. The trading history from December 2, 2024 did not cause price change. The trading delta at closing time against the current closing price is 5.71% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare Prelude Therapeutics to competition |
Other Forecasting Options for Prelude Therapeutics
For every potential investor in Prelude, whether a beginner or expert, Prelude Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Prelude Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Prelude. Basic forecasting techniques help filter out the noise by identifying Prelude Therapeutics' price trends.View Prelude Therapeutics Related Equities
| Risk & Return | Correlation |
Prelude Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Prelude Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Prelude Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Prelude Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Prelude Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Prelude Therapeutics shares will generate the highest return on investment. By undertsting and applying Prelude Therapeutics stock market strength indicators, traders can identify Prelude Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 57929.8 | |||
| Daily Balance Of Power | (0.55) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 1.02 | |||
| Day Typical Price | 1.0 | |||
| Price Action Indicator | (0.07) | |||
| Period Momentum Indicator | (0.06) |
Prelude Therapeutics Risk Indicators
The analysis of Prelude Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Prelude Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting prelude stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.14 | |||
| Standard Deviation | 6.69 | |||
| Variance | 44.72 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Prelude Therapeutics is a strong investment it is important to analyze Prelude Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Prelude Therapeutics' future performance. For an informed investment choice regarding Prelude Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Prelude Therapeutics to cross-verify your projections. For information on how to trade Prelude Stock refer to our How to Trade Prelude Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prelude Therapeutics. If investors know Prelude will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prelude Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.77) | Revenue Per Share 0.04 | Return On Assets (0.39) | Return On Equity (0.67) |
The market value of Prelude Therapeutics is measured differently than its book value, which is the value of Prelude that is recorded on the company's balance sheet. Investors also form their own opinion of Prelude Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Prelude Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prelude Therapeutics' market value can be influenced by many factors that don't directly affect Prelude Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prelude Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Prelude Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prelude Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.